AR069047A1 - Peptidos y lipopeptidos sinteticos antigenicos derivados de mycobacterium avium subsp. paratuberculosis - Google Patents
Peptidos y lipopeptidos sinteticos antigenicos derivados de mycobacterium avium subsp. paratuberculosisInfo
- Publication number
- AR069047A1 AR069047A1 ARP080104673A ARP080104673A AR069047A1 AR 069047 A1 AR069047 A1 AR 069047A1 AR P080104673 A ARP080104673 A AR P080104673A AR P080104673 A ARP080104673 A AR P080104673A AR 069047 A1 AR069047 A1 AR 069047A1
- Authority
- AR
- Argentina
- Prior art keywords
- paratuberculosis
- avium subsp
- mycobacterium avium
- synthetic peptides
- peptide
- Prior art date
Links
- 108010028921 Lipopeptides Proteins 0.000 title abstract 3
- 208000026681 Paratuberculosis Diseases 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 241000186367 Mycobacterium avium Species 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 230000001355 anti-mycobacterial effect Effects 0.000 abstract 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 abstract 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 abstract 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- LQRJAEQXMSMEDP-XCHBZYMASA-N peptide a Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)NCCCC[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)C(\NC(=O)[C@@H](CCCCN)NC(=O)CNC(C)=O)=C/C=1C=CC=CC=1)C(N)=O)C(=O)C(\NC(=O)[C@@H](CCCCN)NC(=O)CNC(C)=O)=C\C1=CC=CC=C1 LQRJAEQXMSMEDP-XCHBZYMASA-N 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 238000011002 quantification Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Diagnósticos y tratamiento de enfermedades que son resultado de la infección con Mycobacterium avium subsp. paratuberculosis. En particular, empleo de un antígeno que se selecciona de entre (a) un péptido sintético 5P que tiene la fórmula siguiente: DPhe-NMeVaI-Ile-Phe-Ala-OMe (SEQ ID Nº 1); (b) un lipopéptido L5P que consiste en el péptido sintético a) y que se caracteriza porque el residuo terminal en N de fenilalanina está acilado en N con una cadena acílica de ácido eicosanoico; (c) una variante del péptido (a) o del lipopéptido (b) que tenga la capacidad de reaccionar con anticuerpos antiMycobacterium paratuberculosis, para la detección o la cuantificación in vitro de anticuerpos específicos antiMycobacterium paratuberculosis en una muestra biológica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07291296A EP2052737A1 (en) | 2007-10-26 | 2007-10-26 | Synthetic antigenic peptides and lipopeptides derived from mycobacterium avium subsp. paratuberculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069047A1 true AR069047A1 (es) | 2009-12-23 |
Family
ID=39281770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080104673A AR069047A1 (es) | 2007-10-26 | 2008-10-27 | Peptidos y lipopeptidos sinteticos antigenicos derivados de mycobacterium avium subsp. paratuberculosis |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8883173B2 (es) |
| EP (3) | EP2052737A1 (es) |
| AR (1) | AR069047A1 (es) |
| CA (1) | CA2703668A1 (es) |
| ES (1) | ES2671709T3 (es) |
| NZ (1) | NZ585476A (es) |
| WO (1) | WO2009053844A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018115924A1 (en) * | 2016-12-20 | 2018-06-28 | Institut Pasteur | Antigenic tripeptides derived from mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof |
| US20230019261A1 (en) * | 2019-12-02 | 2023-01-19 | Temple University-Of The Commonwealth System Of Higher Education | Combinatorial MAP Antibody Tests for Detection and Diagnosis |
| JP7742605B2 (ja) * | 2021-09-14 | 2025-09-22 | 国立大学法人 長崎大学 | 非結核性抗酸菌症の診断を補助する方法および非結核性抗酸菌症の診断補助用キット |
| CN115902217B (zh) * | 2023-03-08 | 2023-06-16 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 一种牛副结核病间接elisa检测试剂盒及其应用 |
| WO2025257153A1 (en) | 2024-06-10 | 2025-12-18 | Institut Pasteur | Antigenic tripeptides derived from mycobacterium avium subsp. paratuberculosis si-type strains, derivatives and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3382208A (en) | 1964-05-15 | 1968-05-07 | Universal Oil Prod Co | Solid organic substrates stabilized with borates of alkanol amines |
-
2007
- 2007-10-26 EP EP07291296A patent/EP2052737A1/en not_active Withdrawn
-
2008
- 2008-10-24 US US12/739,607 patent/US8883173B2/en active Active
- 2008-10-24 ES ES08841534.4T patent/ES2671709T3/es active Active
- 2008-10-24 EP EP18155313.2A patent/EP3406261B1/en active Active
- 2008-10-24 NZ NZ585476A patent/NZ585476A/en not_active IP Right Cessation
- 2008-10-24 EP EP08841534.4A patent/EP2203182B1/en active Active
- 2008-10-24 CA CA2703668A patent/CA2703668A1/en not_active Abandoned
- 2008-10-24 WO PCT/IB2008/003396 patent/WO2009053844A1/en not_active Ceased
- 2008-10-27 AR ARP080104673A patent/AR069047A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3406261B1 (en) | 2024-08-21 |
| US8883173B2 (en) | 2014-11-11 |
| US20110311563A1 (en) | 2011-12-22 |
| EP2203182B1 (en) | 2018-03-21 |
| EP2052737A1 (en) | 2009-04-29 |
| EP2203182A1 (en) | 2010-07-07 |
| EP3406261C0 (en) | 2024-08-21 |
| ES2671709T3 (es) | 2018-06-08 |
| CA2703668A1 (en) | 2009-04-30 |
| NZ585476A (en) | 2012-06-29 |
| EP3406261A1 (en) | 2018-11-28 |
| WO2009053844A1 (en) | 2009-04-30 |
| AU2008315687A1 (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2559062T3 (es) | Método para la activación de linfocitos T colaboradores y composición para su uso en el método | |
| AR110887A2 (es) | Región constante de anticuerpo mutante | |
| EA201791148A1 (ru) | Способ определения абсолютных количеств hla-рестриктированных раковых пептидов, образовавшихся в результате естественного процессинга | |
| RU2010127298A (ru) | Вакцинная композиция против злокачественной опухоли | |
| PE20210376A1 (es) | Peptidos y combinacion de peptidos de origen no canonico para el uso en la inmunoterapia contra diferentes tipos de cancer | |
| AR069047A1 (es) | Peptidos y lipopeptidos sinteticos antigenicos derivados de mycobacterium avium subsp. paratuberculosis | |
| RU2013112616A (ru) | Пептид cdca1 и включающее его фармацевтическое средство | |
| PE20121393A1 (es) | Analogo peptidico de oxintomodulina | |
| RU2010110567A (ru) | Пептид foxm1 и включающее его медицинское средство | |
| ES2545457T3 (es) | Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1 | |
| CY1109837T1 (el) | Διαγνωστικο και θεραπευτικο επιτοπιο | |
| MXPA06003474A (es) | Agonistas de receptores de melanocortina. | |
| NZ703560A (en) | Method for activating helper t cell | |
| AR050050A1 (es) | Factores de virulencia bacteriana y sus usos | |
| BR112015008036A2 (pt) | população de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica e kit | |
| ES2530670T3 (es) | Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo | |
| CL2020003292A1 (es) | Péptido que consiste en la secuencia de aminoácidos de seq id no: 2; anticuerpo que reconoce dicho péptido; receptor de linfocito t; célula hospedadora; linfocito t activado; composición farmacéutica; uso; y kit (divisional de la solicitud no. 201802969) | |
| RU2015130287A (ru) | Адаптация вируса гриппа н5 к человеку | |
| ES2572367T3 (es) | Péptidos con epítopos de la MELK y vacunas que los contienen | |
| AR055179A1 (es) | Procedimiento para la amidacion de polipeptidos con aminoacidos de caracter basico c-terminales mediante el uso de endoproteasas especificas | |
| AR101715A1 (es) | Composiciones útiles para diagnosticar infección latente por mycobacterium tuberculosis | |
| Bittner‐Eddy et al. | Identification of gingipain‐specific I‐A b‐restricted CD 4+ T cells following mucosal colonization with P orphyromonas gingivalis in C 57 BL/6 mice | |
| AR075933A1 (es) | Composiciones polipeptidas y de inmunizacion conteniendo polipeptidos positivos gram y metodos de uso | |
| PE20230343A1 (es) | Peptidos que estimulan respuestas inmunitarias antitumorales | |
| MX2022008298A (es) | Anticuerpo para sesgar proporciones de sexos y metodos de uso del mismo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |